Home » BATTLE OF THE DRUG-ELUTING STENTS
BATTLE OF THE DRUG-ELUTING STENTS
Drug-eluting stents (DES) are superior to bare-metal stents for preventing restenosis,
but few studies have compared the two DES available in the U.S.: sirolimus-eluting
and paclitaxel-eluting. Three new studies have done just that.
MedScape
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May